In preparation for an appendicectomy the anaesthesia was started with thiopentone 350 mg followed by a dose of 24 mg of tubocurarine, intravenously, in a patient with 39° C (102°F) temperature and a history of sensitivity to detergents; an anaphylactoid reaction resulted. The intradermal sensitivity tests to tubocurarine, performed with the skin at room temperature 30°C (85°F) and at 39°C (102°F), were positive and at higher skin temperature the responses were stronger. It was concluded that tubocurarine may induce anaphylactoid reactions in susceptible individuals and that an increase in body temperature acts as a contributory factor.
If an amount of 0.3 mg/kg of tubocurarine is injected fast intravenously the concentration of the drug in plasma at its first circulation through the tissues may reach the threshold of histamine release (Paton, 1959) . A case suggesting such an occurrence is presented.
CASE REPORT
This was the first exposure to anaesthesia and surgery of an 18-year-old male of muscular build, weight 70 kg, admitted to the hospital with a diagnosis of acute appendicitis. The other abnormal findings, from the available data, were a white cell count of 24,000/cujnm with a differential shifted to the left, +2 acetone in the urine, and a rectal temperature of 39 °C (102°F). Surgery was performed on the morning of the day of admission with the removal of an acutely inflamed appendix Preoperatively the patient did not receive any preanaesthetic medication or other drugs and the acetonuria was corrected with an infusion of 1,500 ml of 5% dextrose in Ringer's lactate solution. After a test dose of 6 mg of tubocurarine (tubocurarine chloride, Squibb) injected intravenously without noticeable effects, the anaesthesia was induced with thiopentone 350 mg of a 2.5% solution followed by 24 mg of tubocurarine injected over a 10-sec period. Within 20-30 sec the reaction appeared suddenly as a diffuse rash on the face and neck, macular on the thorax, and as a giant yellowish hive, about 15 cm long, over the vein where the drugs were injected. The lungs were clear on auscultation, the blood pressure stable at 110/70 mm Hg, but the heart rate rose from 100 to 180 beats/min in sinus rhythm as monitored on the cardioscope. The rash and the tachycardia receded spontaneously after 10-15 min and the giant hive after 1 hour. During this time the trachea was intubated and anaesthesia maintained with nitrous cnride-diethyl-ether. Six more mg of tubocurarine was used and at the end the residual curarization was reversed with neostigmine preceded by atropine.
Skin tests.
Skin tests were performed several weeks after the patient left the hospital, four individuals acting as controls. When iniected intradermally, tubocurarine in a concentration of a little less than 0.1 mg/ml produces histamine release (Paton, 1957) . The tests were done on both forearms, one exposed to room temperature, the skin temperature being 30°C (85*F) ±3*Q and the other forearm kept at 39*C (102*F) with a thermal blanket, the temperature at the time of surgery when tubocurarine was injected intravenously. Intradennal weals of about 1 mm diameter were raised with solutions of tubocurarine chloride in 0.9% NaQ, in concentrations of 0.1, 0.067 and 0.05 mg/ml, and plain 0.9% Nad as control. At room temperature three of the controls had positive reactions, papulae of 1.2-0.75 cm in diameter, at concentrations of 0.1 and 0.067 mg/ml, surrounded by a faint erythematous area of about 3 cm, but no reactions at 0.05 mg/ml or 0.9% NaCL Under the same conditions the patient had positive reactions at all three concentrations, with papulae of similar magnitude but with marked erythema. At 39*C (102'F) skin temperature the same three controls reacted positively, this rime at all three concentrations, the papulae being of about the same size as previously but the erythema being more marked. In the patient similar papulae developed and the reaction progressed to a large confluent erythema covering the entire forearm and half of the arm.
DISCUSSION
Two drugs were injected intravenously in close succession and both were able, each through a different mechanism, to release histamine from the tissues.
The release of histamine by thiopentone is mediated through an immunological mechanism. Normally, the organism does not produce antibodies against its own proteins. If a drug or some of its degradation products combines with a protein of the recipient, the complex so formed may act as an antigen able to stimulate specific antibody formation and to react with that antibody on subsequent exposure. The reaction takes place on the surface of the cells, where the antibody is fixed and initiates the process of histamine release from these cells. The responses of "target organs" to histamine acting as a chemical mediator are manifested clinically as anaphylactic reactions (Carr, 1954) . Starting from 1966, seven such cases were reported in the literature, all with a common history of repeated (average eight) exposures to thiopentone (Clark and Cockburn, 1971 ).
In our case there is nothing to suggest the possibility of a previous sensitdzation to thiopentone or to a chemically related drug, the past history of the patient being well documented in the files of the hospital's outpatient department where he was registered since childhood. However, one year previously he had an episode of itching erythematous rash on the body and lacelike rash on the extremities, traced to the use of a laundry detergent, which responded favourably to antihistaminic drugs.
Tubocurarine acts by displacing the histamine, a dibasic substance, from mast cell granules where it is stored bound to heparin and to other substances possessing acid groups. The stability of heparin-histamine complex is enhanced by lowering the temperature or the pH. Basic substances with cationic groups suitably spaced within their molecules, if in sufficient concentrations, may displace and liberate histamine. Among the substances sharing these properties are the opium alkaloids, belladonna alkaloids, trimetaphan camsylate (Arfonad), some detergents and the musderclaxant drugs, in order of decreasing histamineliberating activity, tubocurarine, laudexium, benzoquinonium, decamethonium, suxamethonium and gallamine. The release of histamine by "liberators" may occur on the first exposure to the drug and the responses of histamine-sensitive organs are classified as anaphylactoid reactions (Paton, 1957) .
There is parallelism in the susceptibility of various organs to respond to chemical liberators or to the specific antigens and also quantitative correlation in the percentage of the amounts of histamine released, respectively (Mongar and Schild, 1952) . Although most of the body tissues contain histamine, its release by chemicals or antigens is not equally successful: almost impossible from the intestinal mucosa, which does not contain mast cells, it is difficult from the mast cells located beneath the mucosal tissue of the respiratory system and relatively easy from granulocytes, the basophils containing half of the blood histamine, or from the mast cells distributed in the skin or in the connective tissue along the vessels of the peripheral vascular system. These readily available stores are responsible for most of the reactions attributable to histamine and in this respect the anaphylactic and anaphylactoid reactions share a common symptomatology systematized around the pharmacology of histamine (Mongar and Schild, 1962; Iichtenstein and Norman, 1969) .
In humans, pruritus, urticaria, angioedema, tachycardia and moderate hypotension are the most common manifestations of anaphylactoid reaction, the bronchospasm being uncommon except in individuals with a history of asthma or urticaria. Antihistaminic drugs, while not preventing the release of histamine, are effective antagonists of anaphylactoid reactions but poor antagonists of anaphylactic reactions (Douglas, 1970) .
It is concluded that under clinical conditions of administration tubocurarine can cause anaphylactoid reactions in susceptible individuals and a rise in body temperature may act as a contributory factor.
REACTION GENRE HISTAMINE A LA TUBOCURARINE: DESCRIPTION D'UN CAS

SOMMATRE
En preparation a une appendictomie, on dc'buta l'anesthesie avec 35Omg de thiopentone suivi d'une dose de 24mg de tubocurarine par voie intraveineuse chez un patient avec une temperature de 39 *C et une anamnese de sensibilite' aux detergents; une reaction anaphylactoide se produisit. Les tests intradermaux de sensibility a la tubocurarine, faits sur la peau a temperature de chambre 30 °C et a 39'C, itaient positifs et les reactions itaient plus prononcecs lorsque la temperature cutanee itait plus e'le've*. On conclut que tubocurarine peut produire des reactions anaphylactoides chez des sujets susceptibles et qu'une elevation de la temperature corporelle agit comme facteur contribuant 
RESUMEN
Durante la prcparadtfn para una apendicectomfa la anestesia fue iniciada con 350 mg de tiopcntona seguidos por una dosis de 24 mg de tubccurarina por via intravenosa en un paciente con 39*C (102°F) de temperature y una anamnesis de sensibilidad a los detergentes: Se desarroll6 una reacci6n anafilactica. Las pruebas de sensibilidad intrad^rmica a tubocurarina, llevadas a cabo con la piel a la temperature del cuarto a 30°C (85°F) y 39°C (102*F) fueron positivas y a temperatures cutaneas mis elevadas las respuestas eran mas intensas. Se concluyd que la tubocurarina puede inducir reacciones anafilactoides en individuos susceptibles y que un incremento en la temperatura corporal actua como factor contribuyente.
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